| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |